| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |